Max Gordon, M.D.

Rare Disease / Clinical Research

National Cancer Institute (NCI)

PI on 2 trials

ℹ

Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.

Report missing data

Rare diseases treated or studied

Based on trial PI assignments and publication topics.

Immunodeficiency-associated lymphoproliferative disease
Aggressive primary cutaneous T-cell lymphoma

Clinical trials (2)

NCT00006436
NCT04447027

Verify independently

ClinicalTrials.gov PI search for Max Gordon, M.D.

Other specialists for Immunodeficiency-associated lymphoproliferative disease

Peers ranked by clinical-trial PI role, publications, and verification quality.

Lee Ratner, M.D
Duke University - Duke Cancer Institute LAO
NY
Robert Yarchoan, M.D.
National Cancer Institute (NCI)
Maryland
Ramya M Ramaswami, M.D.
National Cancer Institute (NCI)
Maryland
Glen Lew, MD
Pierre Fabre Laboratories
GA
Federica Cattaneo
Pierre Fabre Laboratories
George Chen
Roswell Park Cancer Institute
Ariela Noy, MD
AIDS Malignancy Consortium
NY
Amrita Y. Krishnan, MD, MD
City of Hope Medical Center
CA

See all specialists for Immunodeficiency-associated lymphoproliferative disease →

← Back to specialists directory